Inactive Instrument
Sector dividends Algeta ASA Xetra
Stocks
GJ9
NO0010239437
Biotechnology & Medical Research
|
End-of-day quote
Xetra
|
||
| - EUR | - |
|
| 14-05-06 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 14-05-06 | Actavis : M&A frenzy in healthcare sector | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1.36% | 1.49% | 21.8x | 5.14x | 7.74x | 15.55x | 17.59x | 74.27B | |
| 0.04% | 0.08% | 31.81x | 6.27x | 9.18x | 28.6x | 29.13x | 61.21B | |
| -.--% | -.--% | 31.83x | 3.34x | 6.79x | 17.62x | 21.12x | 27.55B | |
| -.--% | -.--% | -73.75x | 37.01x | 14.26x | -68.76x | -82.35x | 26.38B | |
| -.--% | -.--% | -15.46x | 1.26x | 5.96x | -7.5x | -5.91x | 25.34B | |
| -.--% | -.--% | 28.48x | 3.39x | 5.36x | 17.82x | 19.98x | 20.84B | |
| -.--% | -.--% | 1066.25x | 17.29x | 37.33x | 644.76x | -241.52x | 14.94B | |
| 0.34% | 0.2% | 43.75x | 10.89x | 16.03x | 32.53x | 35.13x | 15.17B | |
| -.--% | -.--% | 17.96x | 5.53x | 5.35x | 12.5x | 13.25x | 14.41B | |
| -.--% | -.--% | -14.82x | 50.72x | 3341.5x | -17.09x | -14.67x | 13.66B | |
| -.--% | -.--% | -82.17x | 26.7x | 7.51x | -62.2x | -60.88x | 11.99B | |
| -.--% | 0.01% | -417.99x | 8.5x | 15.24x | 950.2x | -280.29x | 11.26B | |
| -.--% | -.--% | -19.74x | 26.06x | 20.2x | -21.97x | -19.52x | 10.15B | |
| -.--% | -.--% | -11.04x | -70.85x | 54.98x | -11.47x | -11.25x | 9.4B | |
| -.--% | -.--% | -7.05x | - | - | -7.29x | -6.75x | 8.78B | |
| -.--% | -.--% | 8.64x | 4.79x | 7.36x | 11.95x | 12.35x | 8.71B | |
| -.--% | -.--% | -31.43x | 8.26x | - | -27.68x | -28.56x | 8.11B | |
| Average | 0.1% | 0.1% | 33.95x | 9.02x | 236.99x | 88.68x | -35.48x | 21.3B | |
| Weighted average by Cap. | 0.3% | 0.33% | 36.20x | 9.21x | 143.44x | 58.73x | -15.72x |
- Stock Market
- Stocks
- ALGETA Stock
- GJ9 Stock
- Sector Algeta ASA
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
